Premiers résultats positifs pour le nirsevimab contre le VRS dans le cadre de l’essai MEDLEY de phase II/III

NEXT STORY
Ramsay Santé tops up its collateral trust, making it one of the largest (€186m) on the French market and the first to be linked to ESG criteria.
PREV STORY
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chembio Receives $8.5 Million Commitment from Bio-Manguinhos to Purchase Components for Production of DPP® Assays in Brazil during 2018

MEDFORD, N.Y., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...

author_avatar
NASDAQ Market News

Gritstone Oncology to Present at Two Upcoming Investor Conferences in August

author_avatar
NASDAQ Market News

Altimmune Announces Positive Results for ALT-702 in Preclinical Model of Colorectal Cancer

author_avatar
NASDAQ Market News